Ceribell Inc. has augmented its leadership team with the appointments of Kristie Rodenbush as chief People Officer and Brian Price as senior vice president of Marketing.

“Ms. Rodenbush and Mr. Price bring an impressive wealth of experience to Ceribell, and I am confident their leadership across our People & Culture and Marketing functions will help us strategically expand our growing team and commercial footprint as we focus on bringing our AI-powered point-of-care EEG neurodiagnostic system to even more hospitals, providing benefit to more patients and providers,” Ceribell Co-Founder/CEO Jane Chao, Ph.D., said. “The magnitude of the unmet need we are addressing is massive: up to one-third of ICU patients are at risk for nonconvulsive seizures. We are proud of our market penetration to date, but there is a significant opportunity for continued growth. Ms. Rodenbush and Mr. Price are important additions to our team, and will play key roles in driving our vital growth initiatives.”

Rodenbush will oversee Ceribell’s People & Culture team. She has more than 25 years of human resources and talent management experience in various industries, including roles at companies ranging from startups to publicly traded, international organizations. Most recently, she was chief People Officer of Meltwater, where she led human resources functions for more than 2,400 employees located in 30 countries. Rodenbush earned a bachelor of arts degree in psychology from the University of California, San Diego.

Price is an industry veteran who brings to Ceribell more than 25 years of experience in the medical device industry, including marketing leadership roles at Medtronic and Abbott. In his new role at Ceribell, he will leverage his expertise in market development, product portfolio planning, business development, health economics, reimbursement, and sales. He most recently served as chief Marketing Officer of VitalConnect, and previously held sales and marketing leadership roles with LivaNova, St. Jude Medical, WebMD, and Guidant Corporation, where he drove multiple incremental product launches and disruptive therapy platforms across many specialties including neurology, cardiology, urology, and gynecology. Price earned an MBA from the University of Minnesota Carlson School of Management and a bachelor of science degree in organizational leadership and industrial technology from Purdue University.

Ceribell is a medical technology company focused on transforming the diagnosis and management of serious neurological conditions. Ceribell has developed the Ceribell System, a point-of-care EEG platform specifically designed to address patients’ unmet needs in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated AI-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is 510(k) cleared by the U.S. Food and Drug Administration for indicating suspected seizure activity and currently is used in U.S. intensive care units and emergency rooms. The firm is headquartered in Sunnyvale, Calif.